A Double-Blind, Placebo-Controlled, Crossover Study of Osmotic Release Oral System Methylphenidate in Adults With ADHD With Assessment of Oppositional and Emotional Dimensions of the Disorder
The DOI matches its Crossref record.
Abstract
BACKGROUND: The realization that attention-deficit/hyperactivity disorder (ADHD) often persists into adulthood has led to increased frequency of diagnosis and treatment in adults. Osmotic release oral system (OROS) methylpheni-date is a long-acting stimulant demonstrated to be effective in the treatment of children and adolescents with ADHD. METHOD: Forty-seven adults entered and 41 completed this double-blind, placebo-controlled, crossover trial of OROS methylphenidate. Each double-blind arm lasted 4 weeks; data were collected from August 2004 through December 2005. Subjects met both DSM-IV-TR and Utah Criteria for ADHD in adults. Outcome measures included the Wender-Reimherr Adult Attention Deficit Disorder Scale (WRAADDS), the adult ADHD-Rating Scale (ADHD-RS), and the Clinical Global Impressions-Improvement scale (CGI-I). At baseline, subjects were categorized as having significant emotional symptoms with the WRAADDS and/or significant oppositional-defiant symptoms using a self-report scale assessing the DSM-IV criteria for oppositional defiant disorder. RESULTS: 17% of the sample (N = 8) had ADHD alone, 38% (N = 18) had ADHD plus significant emotional symptoms, and 40% (N = 19) had ADHD with both significant emotional and oppositional symptoms. At a mean +/- SD dose of 64.0 +/- 23.3 (0.75 mg/kg), OROS methylphenidate proved superior to placebo for all clinical measures: total WRAADDS score decrease of 42% versus 13%, respectively, p < .001 and total ADHD-RS score decrease of 41% versus 14%, respectively, p = .003, plus the subscales addressing inattention, hyperactivity/ impulsivity, and emotional dysregulation. CONCLUSIONS: OROS methylphenidate proved effective in treating adult ADHD. ADHD alone was relatively uncommon. Over 80% of our patients had ADHD with a combination of emotional and/or oppositional symptoms.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This has been supported to some extent by recent clinic-based studies reporting impairing emotion dysregulation in between 34-70% of adults with ADHD, although population based studies are needed (69-73)–Table 1.”
From Emotion Dysregulation in Attention Deficit Hyperactivity Disorder (2014) · cites this paper as [72]
In the citing paper
“The paucity of empirical support for stimulant effects on emotional lability stands in stark contrast with the numerous, randomized clinical trials demonstrating stimulant’s short term efficacy on the diagnostic symptoms of ADHD [32, 33].”
From Using Stimulants to Treat ADHD-Related Emotional Lability (2014) · cites this paper as [33]
In the citing paper
“Recent trials in ADHD patients indicate that besides ADHD symptoms, mood instability improves with both stimulant treatment and atomoxetine [234,235].”
From European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD (2010) · cites this paper as [234]
In the citing paper
“Symptoms such as demoralisation and low self-esteem following a life with ADHD, and mood instability, improve with stimulant treatment alone [234].”
From European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD (2010) · cites this paper as [234]
Citations
Cites
Still being checked.
Cited by
Emotion Dysregulation in Attention Deficit Hyperactivity Disorder
Shaw, P., Stringaris, A., Nigg, J., & Leibenluft, E. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.13070966 · Cited by 1,232
Kooij, S. J., Bejerot, S., Blackwell, A., Caci, H., Casas-Brugué, M., Carpentier, P. J., Edvinsson, D., Fayyad, J., Foeken, K., Fitzgerald, M., et al. (2010) · BMC Psychiatry · doi:10.1186/1471-244x-10-67 · Cited by 928
“Symptoms such as demoralisation and low self-esteem following a life with ADHD, and mood instability, improve with stimulant treatment alone [234].”
Faraone, S. V., & Glatt, S. J. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04902pur · Cited by 387
Maternal emotion and cognitive control capacities and parenting: A conceptual framework
Crandall, A., Deater-Deckard, K., & Riley, A. W. (2015) · Developmental Review · doi:10.1016/j.dr.2015.01.004 · Cited by 371
Adult attention-deficit hyperactivity disorder: key conceptual issues
Asherson, P., Buitelaar, J., Faraone, S. V., & Rohde, L. A. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30032-3 · Cited by 347
Estimating the size of treatment effects: moving beyond p values.
McGough, J. J., & Faraone, S. V. (2009) · PubMed · Cited by 369
Skirrow, C., McLoughlin, G., Kuntsi, J., & Asherson, P. (2009) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.2 · Cited by 217
Castells, X., Ramos-Quiroga, J. A., Rigau, D., Bosch, R., Nogueira, M., Vidal, X., & Casas, M. (2011) · CNS Drugs · doi:10.2165/11539440-000000000-00000 · Cited by 197
Medori, R., Ramos-Quiroga, J. A., Casas, M., Kooij, J. J. S., Niemelä, A., Trott, G.-E., Lee, E., & Buitelaar, J. K. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.11.008 · Cited by 186
Treatment of adults with attention-deficit/hyperactivity disorder
Hechtman, L. (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s6985 · Cited by 157
Fredriksen, M., Halmøy, A., Faraone, S. V., & Haavik, J. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.07.016 · Cited by 173
Distinguishing comorbidity and successful management of adult ADHD
Kooij, J. J. S., Huss, M., Asherson, P., Akehurst, R., Beusterien, K., French, A., Sasané, R., & Hodgkins, P. (2012) · Journal of Attention Disorders · doi:10.1177/1087054711435361 · Cited by 172
Emotional dysregulation in adult ADHD: what is the empirical evidence?
Retz, W., Stieglitz, R.-D., Corbisiero, S., Retz-Junginger, P., & Rösler, M. (2012) · Expert Review of Neurotherapeutics · doi:10.1586/ern.12.109 · Cited by 168
Young, S. J., Adamou, M., Bolea, B., Gudjonsson, G., Müller, U., Pitts, M., Thome, J., & Asherson, P. (2011) · BMC Psychiatry · doi:10.1186/1471-244x-11-32 · Cited by 166
How is affective instability defined and measured? A systematic review
Marwaha, S., He, Z., Broome, M., Singh, S. P., Scott, J., Eyden, J., & Wolke, D. (2014) · Psychological Medicine · doi:10.1017/s0033291713002407 · Cited by 161
Surman, C. B. H., Biederman, J., Spencer, T., Miller, C. A., McDermott, K. M., & Faraone, S. V. (2013) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-012-0100-8 · Cited by 155
on behalf of the study group, Rösler, M., Fischer, R., Ammer, R., Ose, C., & Retz, W. (2009) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-008-0845-4 · Cited by 155
Evidence of emotion dysregulation as a core symptom of adult ADHD: A systematic review
Soler-Gutiérrez, A.-M., Pérez-González, J.-C., & Mayas, J. (2023) · PLOS ONE · doi:10.1371/journal.pone.0280131 · Cited by 152
Attention deficit hyperactivity disorder in adults
Rösler, M., Casas, M., Konofal, E., & Buitelaar, J. (2010) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2010.483249 · Cited by 143
Do prescription stimulants increase the risk of adverse cardiovascular events?: A systematic review
Westover, A. N., & Halm, E. A. (2012) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-12-41 · Cited by 140
Koesters, M., Becker, T., Kilian, R., Fegert, J., & Weinmann, S. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881108092338 · Cited by 142
Asherson, P., Young, A. H., Eich-Höchli, D., Moran, P., Porsdal, V., & Deberdt, W. (2014) · Current Medical Research and Opinion · doi:10.1185/03007995.2014.915800 · Cited by 130
Lenzi, F., Cortese, S., Harris, J., & Masi, G. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.08.010 · Cited by 141
“The meta-analysis of the 13 methylphenidate studies (Biederman et al., 2011; Jain et al., 2007; Marchant et al., 2011; Medori et al., 2008; Philipsen et al., 2015; Reimherr et al., 2007; Retz et al., 2012a,b; Rosler et al., 2010; Tenenbaum et al., 2002; Wender et al., 1985, 2011; Wigal et al., 2016; Goodman et al., 20…”
InfluentialIs emotional dysregulation part of the psychopathology of ADHD in adults?
Corbisiero, S., Stieglitz, R.-D., Retz, W., & Rösler, M. (2013) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-012-0097-z · Cited by 139
Mick, E., McManus, D. D., & Goldberg, R. J. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.06.011 · Cited by 134
Surman, C. B. H., Biederman, J., Spencer, T., Yorks, D., Miller, C. A., Petty, C. R., & Faraone, S. V. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.10081172 · Cited by 135
Peterson, K., McDonagh, M. S., & Fu, R. (2008) · Psychopharmacology · doi:10.1007/s00213-007-0996-4 · Cited by 135
Rösler, M., Retz, W., Fischer, R., Ose, C., Alm, B., Deckert, J., Philipsen, A., Herpertz, S., & Ammer, R. (2010) · The World Journal of Biological Psychiatry · doi:10.3109/15622971003624197 · Cited by 131
“The OROS-MPH study by Reimherr et al. (2007) had an observation period of 4 weeks.”
BackgroundMethodResultInfluentialAn update on the pharmacotherapy of attention-deficit/hyperactivity disorder in adults
Wilens, T. E., Morrison, N. R., & Prince, J. (2011) · Expert Review of Neurotherapeutics · doi:10.1586/ern.11.137 · Cited by 112
An update on the debated association between ADHD and bipolar disorder across the lifespan
Skirrow, C., Hosang, G. M., FARMER, A. E., & Asherson, P. J. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.04.003 · Cited by 121
Adler, L. A., Zimmerman, B., Starr, H. L., Silber, S., Palumbo, J., Orman, C., & Spencer, T. (2009) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181a390ce · Cited by 106
Corbisiero, S., Mörstedt, B., Bitto, H., & Stieglitz, R. (2017) · Journal of Clinical Psychology · doi:10.1002/jclp.22317 · Cited by 93
Zalsman, G., & Shilton, T. (2016) · International Journal of Psychiatry in Clinical Practice · doi:10.3109/13651501.2016.1149197 · Cited by 84
Elliott, J., Johnston, A., Husereau, D., Kelly, S., Eagles, C., Charach, A., Hsieh, S., Bai, Z., Hossain, A., Skidmore, B., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0240584 · Cited by 111
Ditrich, I., Philipsen, A., & Matthies, S. (2021) · Borderline Personality Disorder and Emotion Dysregulation · doi:10.1186/s40479-021-00162-w · Cited by 111
Merwood, A., Chen, W., Rijsdijk, F., Skirrow, C., Larsson, H., Thapar, A., Kuntsi, J., & Asherson, P. (2014) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2013.11.006 · Cited by 84
Gibbins, C., & Weiss, M. D. (2007) · Current Psychiatry Reports · doi:10.1007/s11920-007-0055-1 · Cited by 94
Retz, W., Rösler, M., Ose, C., Scherag, A., Alm, B., Philipsen, A., Fischer, R., Ammer, R., & The Study Group (2012) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2010.540257 · Cited by 79
Biederman, J., Spencer, T., Lomedico, A., Day, H., Petty, C. R., & Faraone, S. V. (2012) · Psychological Medicine · doi:10.1017/s0033291711001644 · Cited by 78
“These findings are consistent with prior work, indicating that ADHD is associated with DESR (Reimherr et al. 2005, 2007 ; Barkley et al. 2008 ; Barkley & Fischer, 2010).”
ResultHong, S.-B., Harrison, B. J., Fornito, A., Sohn, C.-H., Song, I.-C., & Kim, J.-W. (2015) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.130290 · Cited by 72
The Positive Illusory Bias: Does It Explain Self-Evaluations in College Students With ADHD?
Prevatt, F., Proctor, B., Best, L., Baker, L., Van Walker, J., & Taylor, N. W. (2012) · Journal of Attention Disorders · doi:10.1177/1087054710392538 · Cited by 71
Szomlaiski, N., Dyrborg, J., Rasmussen, H., Schumann, T., Koch, S., & Bilenberg, N. (2009) · Acta Paediatrica · doi:10.1111/j.1651-2227.2008.01025.x · Cited by 73
Madhoo, M., Keefe, R. S., Roth, R. M., Sambunaris, A., Wu, J., Trivedi, M. H., Anderson, C. S., & Lasser, R. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2013.334 · Cited by 74
Huntley, Z., Maltezos, S., Williams, C., Morinan, A., Hammon, A., Ball, D., Marshall, E. J., Keaney, F., Young, S., Bolton, P., et al. (2012) · BMC Psychiatry · doi:10.1186/1471-244x-12-223 · Cited by 68
Chao, C., Gau, S. S. F., Mao, W., Shyu, J., Chen, Y., & Yeh, C. (2008) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2008.01830.x · Cited by 64
Using Stimulants to Treat ADHD-Related Emotional Lability
Posner, J., Kass, E., & Hulvershorn, L. (2014) · Current psychiatry reports · doi:10.1007/s11920-014-0478-4 · Cited by 66
Psychometric properties of the Wender-Reimherr Adult Attention Deficit Disorder Scale.
Marchant, B. K., Reimherr, F. W., Robison, D., Robison, R. J., & Wender, P. H. (2013) · Psychological Assessment · doi:10.1037/a0032797 · Cited by 63
Self-citationSantosh, P. J., Sattar, S., & Canagaratnam, M. (2011) · CNS Drugs · doi:10.2165/11593070-000000000-00000 · Cited by 62
Reimherr, F. W., Marchant, B. K., Gift, T. E., Steans, T. A., & Wender, P. H. (2015) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-015-0176-z · Cited by 63
Self-citationMoukhtarian, T. R., Cooper, R. E., Vassos, E., Moran, P., & Asherson, P. (2017) · European Psychiatry · doi:10.1016/j.eurpsy.2017.05.021 · Cited by 56
“5% of the initially recruited participants dropped out prior to randomisation and another 12% following randomisation [19], and in another study, four subjects were eliminated after randomisation [30], raising concerns about the likelihood of selection bias.”
BackgroundRamos-Quiroga, J. A., Bosch, R., Castells, X., Valero, S., Nogueira, M., Gómez, N., Yelmo, S., Ferrer, M., Martínez, Y., & Casas, M. (2008) · CNS Drugs · doi:10.2165/00023210-200822070-00005 · Cited by 54
Emotion Dysregulation in Attention Deficit Hyperactivity Disorder
Shaw, P., Stringaris, A., Nigg, J., & Leibenluft, E. (2016) · Focus · doi:10.1176/appi.focus.140102 · Cited by 47
Varrasi, S., Boccaccio, F. M., Guerrera, C. S., Platania, G. A., Pirrone, C., & Castellano, S. (2022) · Education Sciences · doi:10.3390/educsci13010037 · Cited by 37
Skirrow, C., McLoughlin, G., Banaschewski, T., Brandeis, D., Kuntsi, J., & Asherson, P. J. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.09.015 · Cited by 56
Internalizing and externalizing behavior in adult ADHD
Jacob, C., Groß‐Lesch, S., Jans, T., Geissler, J. M., Reif, A., Dempfle, A., & Lesch, K. (2014) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-014-0128-z · Cited by 60
Methylphenidate Transdermal System in Adult ADHD and Impact on Emotional and Oppositional Symptoms
Marchant, B. K., Reimherr, F. W., Robison, R. J., Olsen, J. L., & Kondo, D. G. (2011) · Journal of Attention Disorders · doi:10.1177/1087054710365986 · Cited by 51
“Adult ODD was defined using previously developed criteria of scores ≥ 17 on this scale (Reimherr et al., 2007; in press).”
BackgroundMethodResultInfluentialSelf-citationAttention-Deficit/Hyperactivity Disorder in Adults: Evidence-Based Recommendations for Management
Rostain, A. L. (2008) · Postgraduate Medicine · doi:10.3810/pgm.2008.09.1905 · Cited by 50
Adler, L. A., Orman, C., Starr, H. L., Silber, S., Palumbo, J., Cooper, K., Berwaerts, J., & Harrison, D. D. (2011) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318203ea0a · Cited by 47
Treatment of adult ADHD: Is current knowledge useful to clinicians?
Torgersen, T. (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s1223 · Cited by 48
Pharmacotherapy of ADHD in Adults
Wilens, T. E. (2008) · CNS Spectrums · doi:10.1017/s1092852900002960 · Cited by 50
Marchant, B. K., Reimherr, F. W., Halls, C., Williams, E. D., Strong, R. E., Kondo, D. G., Soni, P., & Robison, R. J. (2011) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-011-0054-2 · Cited by 55
Self-citationGürkan, K., Bilgiç, A., Türkoğlu, S., Kılıç, B. G., Aysev, A., & Uslu, R. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881109348172 · Cited by 44
ADHD: Overdiagnosed and overtreated, or misdiagnosed and mistreated?
Manos, M. J., Giuliano, K., & Geyer, E. (2017) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.84a.15051 · Cited by 48
Silverstein, M. J., Faraone, S. V., Alperin, S., Leon, T. L., Biederman, J., Spencer, T. J., & Adler, L. A. (2019) · Journal of Attention Disorders · doi:10.1177/1087054718756198 · Cited by 40
Katzman, M. A., & Sternat, T. (2014) · CNS Drugs · doi:10.1007/s40263-014-0175-1 · Cited by 48
Castells, X., Cunill, R., & Capellà, D. (2013) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-012-1390-7 · Cited by 41
The use of stimulants and atomoxetine in adults with comorbid ADHD and bipolar disorder
Perugi, G., & Vannucchi, G. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.1079620 · Cited by 41
Pharmacological treatment of adult ADHD in Europe
Retz, W., Retz-Junginger, P., Thome, J., & Rösler, M. (2011) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2011.603229 · Cited by 36
Vidal, R., Valero, S., Nogueira, M., Palomar, G., Corrales, M., Richarte, V., Bosch, R., Gómez-Barros, N., Corominas, M., Casas, M., et al. (2014) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2014.07.001 · Cited by 36
“In the same line, psychopharmacological treatments for ADHD have shown to reduce ADHD symptoms in parallel with EL in adults [17,35–38] and also in children [39,40] suggesting that EL could be an intrinsic symptom of ADHD.”
BackgroundBen-Dor Cohen, M., Eldar, E., Maeir, A., & Nahum, M. (2021) · Health and Quality of Life Outcomes · doi:10.1186/s12955-021-01904-8 · Cited by 35
“Similar ED scale based on the WRAADDS has been used in several previous studies [29, 30, 38, 39, 54].”
MethodSurman, C. B. H., Biederman, J., Spencer, T., Miller, C. A., Petty, C. R., & Faraone, S. V. (2015) · Journal of Attention Disorders · doi:10.1177/1087054713476548 · Cited by 35
Retz, W., & Retz‐Junginger, P. (2014) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-014-0542-4 · Cited by 37
Perugi, G., Pallucchini, A., Rizzato, S., Pinzone, V., & Rossi, P. D. (2019) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2019.1618270 · Cited by 43
Gamlı, İ. S., & Tahiroğlu, A. Y. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s164807 · Cited by 39
The latent structure of attention deficit/hyperactivity disorder in an adult sample
Marcus, D. K., Norris, A. L., & Coccaro, E. F. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.03.010 · Cited by 37
Toward Quality Care in ADHD: Defining the Goals of Treatment
Rostain, A., Jensen, P. S., Connor, D. F., Miesle, L. M., & Faraone, S. V. (2015) · Journal of Attention Disorders · doi:10.1177/1087054712473835 · Cited by 33
Faraone, S. V. (2012) · Journal of Attention Disorders · doi:10.1177/1087054710379738 · Cited by 33
Robison, R. J., Reimherr, F. W., Gale, P. D., Marchant, B. K., Williams, E. D., Soni, P., Halls, C., & Strong, R. E. (2010) · Annals of Clinical Psychiatry · doi:10.1177/104012371002200204 · Cited by 35
Self-citationBiederman, J., DiSalvo, M., Woodworth, K. Y., Fried, R., Uchida, M., Biederman, I., Spencer, T. J., Surman, C., & Faraone, S. V. (2020) · European Psychiatry · doi:10.1192/j.eurpsy.2019.11 · Cited by 31
The latent structure of oppositional defiant disorder in children and adults
Barry, T. D., Marcus, D. K., Barry, C. T., & Coccaro, E. F. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.08.016 · Cited by 33
Wigal, T. L., Newcorn, J. H., Handal, N. M., Wigal, S. B., Mulligan, I., Schmith, V. D., & Konofal, É. (2018) · CNS Drugs · doi:10.1007/s40263-018-0503-y · Cited by 32
Bitaubé, J. A., López‐Martín, S., Fernández‐Jaén, A., & Arangüena, L. C. (2008) · Revista de Neurología · doi:10.33588/rn.4701.2008111 · Cited by 77
Brown, T. E., Brams, M., Gao, J., Gasior, M., & Childress, A. (2010) · Postgraduate Medicine · doi:10.3810/pgm.2010.09.2196 · Cited by 29
Weisler, R. H., & Goodman, D. W. (2008) · Primary psychiatry · Cited by 39
Oros Methylphenidate in the Treatment of Adults with Adhd: A 6-Month, Open-Label, Follow-Up Study
Marchant, B. K., Reimherr, F. W., Halls, C., Williams, E. D., & Strong, R. E. (2010) · Annals of Clinical Psychiatry · doi:10.1177/104012371002200309 · Cited by 32
Self-citationKim, B., Kim, J.-W., Hong, S., Cho, S.-C., Shin, M., & Yoo, H. (2010) · Behavioral and Brain Functions · doi:10.1186/1744-9081-6-57 · Cited by 31
Rösler, M., Ginsberg, Y., Arngrim, T., Adamou, M., Niemelä, A., Dejonkheere, J., van Oene, J., & Schäuble, B. (2011) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2011.571283 · Cited by 28
Extended-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults
Boesen, K., Paludan‐Müller, A. S., Gøtzsche, P. C., & Jørgensen, K. J. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012857.pub2 · Cited by 37
Mörstedt, B., Corbisiero, S., Bitto, H., & Stieglitz, R. (2015) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-015-0181-2 · Cited by 32
Weibel, S., Micoulaud‐Franchi, J., Brandejsky, L., Lopez, R., Prada, P., Nicastro, R., Ardu, S., Dayer, A. G., Lançon, C., & Perroud, N. A. (2017) · Journal of Attention Disorders · doi:10.1177/1087054717690808 · Cited by 29
Resting-State fMRI Study of ADHD and Internet Gaming Disorder
Han, D. H., Bae, S., Hong, J., Kim, S. M., Son, Y. D., & Renshaw, P. F. (2019) · Journal of Attention Disorders · doi:10.1177/1087054719883022 · Cited by 28
Olsen, J. L., Reimherr, F. W., Marchant, B. K., Wender, P. H., & Robison, R. J. (2012) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.12m01344 · Cited by 26
Self-citationAsherson, P., Stes, S., Nilsson Markhed, M., Berggren, L., Svanborg, P., Kutzelnigg, A., & Deberdt, W. (2015) · European Psychiatry · doi:10.1016/j.eurpsy.2014.12.002 · Cited by 25
Brown, T. E., Brams, M., Gasior, M., Adeyi, B., Babcock, T., Dirks, B., Scheckner, B., & Wigal, T. (2011) · Current Medical Research and Opinion · doi:10.1185/03007995.2011.605441 · Cited by 24
Challis (2009) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s6873 · Cited by 23
Childress, A. C., & Sallee, F. R. (2015) · CNS Drugs · doi:10.1007/s40263-015-0264-9 · Cited by 23
Reimherr, F. W., Marchant, B. K., Williams, E. D., Strong, R. E., Halls, C., & Soni, P. (2010) · Annals of Clinical Psychiatry · doi:10.1177/104012371002200205 · Cited by 21
Self-citationSafety of stimulant treatment in attention deficit hyperactivity disorder: part II
Merkel, R. L. (2010) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2010.503238 · Cited by 23
Safety of stimulant treatment in attention deficit hyperactivity disorder: part I
Merkel, R. L., & Kuchibhatla, A. (2009) · Expert Opinion on Drug Safety · doi:10.1517/14740330903279956 · Cited by 23
Oppositional Defiant Disorder in Adults With ADHD
Reimherr, F. W., Marchant, B. K., Olsen, J. L., Wender, P. H., & Robison, R. J. (2011) · Journal of Attention Disorders · doi:10.1177/1087054711425774 · Cited by 22
Self-citation
Metadata
- Authors
- Reimherr, F. W., Williams, E. D., Strong, R. E., Mestas, R., Soni, P., & Marchant, B. K.
- Affiliations
- University of Utah (US)
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2007-01-15
- Volume
- 68
- Issue
- 01
- Pages
- 93-101
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2025163293
- Cited by
- 180
- References
- 0
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 3 · 2023: 4 · 2022: 5 · 2021: 5 · 2020: 3 · 2019: 2 · 2018: 7 · 2017: 11 · 2016: 9 · 2015: 12 · 2014: 15 · 2013: 11 · 2012: 16
- FWCI
- 10.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
- Keywords
- adult ADHD, OROS methylphenidate, long-acting stimulants, oppositional defiant disorder, emotional dysregulation, emotional symptoms, inattention, hyperactivity/impulsivity, ADHD Rating Scale, treatment efficacy
- MeSH terms
- Administration, Oral, Adult, Affective Symptoms, Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Delayed-Action Preparations, Double-Blind Method, Female, Humans, Male, Methylphenidate, Middle Aged, Osmosis, Treatment Outcome, Cross-Over Studies, Attention Deficit and Disruptive Behavior Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.